Pedro Alvarez-Urena, Ph.D

Senior Associate, Research

Headshot photo of Pedro Alvarez-Urena

Dr. Alvarez-Urena joined Cowen Healthcare Investments in February 2018. He performs research into novel therapeutic approaches and conducts due diligence on private and public healthcare companies. Dr. Alvarez-Urena serves as a Board Observer of Scipher Medicines and previously served as Board Observer for Oncorus and Personal Genome Diagnostics. He is also currently a member of the Advisory Board of DRIVEN Accelerator Hub from Celdara Medical LLC. He previously worked as a postdoctoral researcher at the University of Pennsylvania while consulting for a Boston-based venture capital firm and for Philadelphia-based venture capitalists and biotechnology companies. His scientific background is in the study and development of polymers to deliver drugs, particularly genetically engineered proteins, small molecules and RNAi,  as well as for improving the efficacy/safety of cell and gene therapy agents.

Dr. Alvarez-Urena holds a Ph.D. in Biomedical Engineering from Carnegie Mellon University, and was a Postdoctoral Fellow in Cell and Gene Therapy at Baylor College of Medicine.

Get In Touch

Start a conversation with Pedro Alvarez-Urena

Investment Management Team

Our team of dedicated investment professionals seek to capitalize on disruption and dislocation across market, geographies and sectors.

View More
Investment management professional reviews report with a client